ARC Finance Limited Overview
ARC Finance Limited is a 44-year-old Kolkata company that began life as ARC Modellors & Services, became a finance company in 1993 and has held an RBI licence as a non-deposit-taking NBFC since 1998. It lends money (secured and unsecured, to individuals and corporates), invests and trades in securities, and says it has diversified into third-party financial-product distribution. With a balance sheet of about INR 114 Cr, net worth of about INR 99 Cr and a loan book of about INR 87 Cr at March 2026, it sits in the Base Layer of RBI's scale-based framework, among several thousand small NBFCs. Its distinctive features are capital-markets rather than operational: a 4-for-5 rights issue in late 2024 that nearly doubled the share count and equity; promoter ownership of only 6.97%; and a shareholder base that grew from about 1,100 in 2021 to over 3 lakh. Profitability is thin and erratic, with a three-year average ROE below 2%.
Company's own description. In its annual-report material (as summarised by Screener from the FY2025 annual report), the company describes itself as a non-systemically-important, non-deposit-taking NBFC. It says it advances loans, invests in and trades securities, and has diversified into businesses ranging from third-party product distribution (described as the lowest balance-sheet risk) to originating unsecured personal loans and corporate loans (described as the highest balance-sheet risk). It also says it offers a range of other financial services to customers. Older corporate summaries add that around 2015 the company, which had manufacturing and trading activities in agricultural and other products, took up financial and investment activities.
Independent characterisation. The financial statements describe a business with three income engines whose relative weight cannot be fully separated from public data:
-
Interest income on loans. The loan book is the clearest operating asset. It appears on the balance sheet only from FY2024 (INR 44.57 Cr), rising to INR 69.96 Cr at FY2025 and INR 86.90 Cr at FY2026 (Finology; Whalesbook summary of FY2026 results). Loans were 76% of total assets at March 2026 (derived). The growth was funded mainly by the INR 44 Cr rights issue rather than borrowing.
-
Securities investment and trading. The company holds stock-in-trade and investments. Reported revenue swings sharply from quarter to quarter: Q2 FY2026 total revenue of INR 20.05 Cr against INR 0.82 Cr in Q1 and INR 1.58 Cr in Q3 (HDFC Sky). That pattern fits lumpy sales of securities booked as revenue, not steady interest accrual.
-
Distribution and fee income. The company mentions third-party product distribution, but the materials reviewed do not quantify it.
Revenue model mix. Capital Market (via Business Standard) reports FY2026 "Sales" of INR 6.14 Cr, while revenue from operations was INR 28.09 Cr. The difference of about INR 22 Cr most plausibly reflects proceeds from sale of securities/stock-in-trade, which aggregators handle inconsistently. This is the analyst's inference and has not been confirmed against the notes to accounts. On that reading, the more recurring interest/fee component was about INR 6 Cr in FY2026, roughly 7% of the average loan book (derived). That is a plausible yield for a small NBFC lending to related or semi-related corporate borrowers and individuals.
Value-chain position. ARC is a balance-sheet lender funded almost entirely by equity (debt/equity 0.01 at FY2025, Value Research). It has no disclosed branch network, digital platform, co-lending arrangements or bank funding lines. It is a capital provider, not an originator-distributor.
Customer types and end-markets. The filings name only broad categories: individuals (unsecured personal loans) and corporates (corporate loans). Borrower concentration, geography, ticket sizes and sector exposures are not publicly disclosed. Given the Kolkata registered office and the absence of a branch network, the lending is likely concentrated in eastern India and in a small number of counterparties. This is the analyst's inference.
Strategy
Stated strategy. ARC does not hold investor days, publish investor presentations or give guidance. The only articulated strategic theme in annual-report material is a risk-tiered diversification: from third-party distribution (low balance-sheet risk) to unsecured personal and corporate lending (high balance-sheet risk). Corporate-governance sections describe an ethics-led approach that combines voluntary best practice with legal compliance and staff empowerment (paraphrased from aggregator summaries of the annual report).
Initiatives in the last 24 months (Oct 2024 – Oct 2026).
ESG/sustainability commitments: none disclosed.
Cost programmes: none disclosed.
Medium-term financial targets / guidance: none disclosed.
Given the subsequent loan growth, the funds appear to have been deployed largely into lending (analyst inference, consistent with balance-sheet movements).
Products & Services
ARC Finance does not publish a product catalogue, brand names, rate cards or a digital lending app in the sources reviewed. The catalogue below reflects every offering the company itself names.
Observations. The absence of named products, published interest rates, a grievance-redress product matrix or digital channels is typical of Base-Layer NBFCs whose lending is relationship-driven and concentrated. The company's risk spectrum framing (distribution lowest, unsecured/corporate loans highest) is the only disclosed portfolio strategy.
Product Portfolio
| Offering | Description | Target customer | Launch / latest version | Pricing model | Flagship / brand |
|---|---|---|---|---|---|
Corporate loans | Term/working-capital-type lending to companies | Corporates (identity, sector and size not disclosed) | Lending visible on balance sheet from FY2024 | Interest-bearing; rates not disclosed | None named |
Unsecured personal loans | Loans to individuals without collateral | Retail individuals | Mentioned in FY2025 annual-report business description | Interest-bearing; rates not disclosed | None named |
Secured loans | Collateralised loans | Individuals/corporates | Mentioned in rights-issue documentation summaries | — | None named |
Investment in securities | Holding equity/other instruments for investment | Proprietary | Ongoing since 2015 diversification | Returns via dividends/fair-value gains | — |
Trading in securities | Buying and selling securities (stock-in-trade) | Proprietary | Ongoing | Trading gains/sale proceeds | — |
Third-party product distribution | Distribution of other providers' financial products | Retail/corporate clients | Mentioned in FY2025 annual-report description | Commission-based (assumed; not disclosed) | None named |
Other financial services | Unspecified "variety of financial services" | Customers generally | — | — | — |
“—” = not publicly disclosed.
Financial Narrative
All figures are standalone, INR Cr, fiscal years ending 31 March. Sources: Value Research, Finology Ticker, MoneyWorks4Me, Screener, Business Standard/Capital Market, FY2025 Directors' Report, Whalesbook (FY2026 results summary). Blank cells = not publicly disclosed in sources retrieved.
Income statement
Notes:
-
FY2021 total income is about INR 4.18 Cr (derived from Value Research's +679.9% FY2022 growth) and PAT INR 0.18 Cr. On that base the 5-year revenue CAGR FY2021–FY2026 is about 46% (derived). The 4-year CAGR FY2022–FY2026 is about −3.6% (derived). The difference shows how sensitive growth rates are to the FY2022 spike.
-
Gross profit and EBITDA are not meaningful for an NBFC and are not reported. "Operating profit" above is an aggregator construct (Indmoney/Screener definition) and differs from Capital Market's PBDT.
-
The derived EPS uses period-end shares (50.50 Cr pre-split equivalent through FY2024; 87.15 Cr thereafter), so it understates FY2025 EPS, when the weighted-average count was lower. Finology reported EPS declining 16.3% YoY for FY2024.
-
Total expenses FY2024 and FY2025 are from the FY2025 Directors' Report ("expenditure" of INR 8.59 Cr and INR 16.93 Cr). FY2026 is from the results summary (INR 27.11 Cr, +51.7% YoY per Whalesbook; the bases differ slightly).
Commentary. The P&L shows no stable trend. FY2022 revenue of INR 32.6 Cr, almost eight times FY2021, coincided with the retail speculative surge in the stock. It was followed by a 79% collapse in FY2023. In both cases PAT stayed between INR 0.28 and 0.33 Cr, a sign that the revenue line is dominated by pass-through securities sales with near-zero margin. FY2025 is the only year of meaningful profit (INR 3.31 Cr). It was earned almost entirely in the first two quarters (Q1 INR 3.06 Cr; Q2 about INR 3.37 Cr derived), partly reversed by a Q4 loss of INR 3.46 Cr (likely mark-to-market or impairment; the cause was not disclosed in the sources reviewed). FY2026 revenue rose 20.6%, but expenses rose faster and PAT fell 78% to INR 0.72 Cr. Underlying profitability on the equity base is roughly 0.5–1% a year outside FY2025.
Quarterly run-rate (INR Cr)
Sources: HDFC Sky (total revenue, net profit); Business Standard/Capital Market and Askfuzz summaries ("Sales"); BSE filing for Q1 FY2027 (revenue INR 184.35 lakh, expenses INR 161.78 lakh, profit INR 16.70 lakh). The four FY2026 quarters sum to INR 28.09 Cr, which reconciles to the annual figure.
Balance sheet
Sources: Screener (capital, reserves, total assets FY2022–FY2026); MoneyWorks4Me (borrowing split FY2022–FY2025); Finology (loans FY2024–FY2025); Whalesbook (loans FY2026); Multibagg (investments). Net worth, non-equity liabilities and BVPS derived. Book value per share is shown on the post-split INR 1 face-value basis throughout.
Data-quality notes:
Cash and equivalents: not reliably disclosed in retrievable sources. Tracxn shows obfuscated values, which are excluded.
Goodwill and intangibles: none disclosed; the company has no acquisitions.
FY2024 reserves anomaly: reserves fell from INR 1.12 Cr to INR 0.68 Cr despite PAT of INR 0.27 Cr.
FY2026 liabilities: non-equity liabilities rose from about INR 2 Cr to about INR 15 Cr (derived). The composition (borrowings vs payables vs provisions) is not publicly disclosed in sources retrieved. This is a monitorable item: it implies the company resumed some external funding or accrued material payables in FY2026.
Working capital: not a meaningful construct for an NBFC. Screener's legacy "current assets" fell from INR 69–79 Cr (FY2022–FY2023) to INR 25–29 Cr (FY2024–FY2025) as assets were reclassified to loans, then rose to INR 92 Cr at FY2026 (Value Research TTM). Classification changes make this series unreliable.
Cash flow
Operating cash flow, investing cash flow and capex are not publicly disclosed in sources retrieved (Screener's cash-flow table was not rendered). For an NBFC, operating cash flow is dominated by loan disbursements. The INR 25 Cr rise in loans in FY2025 and INR 17 Cr rise in FY2026 imply strongly negative operating cash flows, financed by the rights issue (derived inference). Capex is negligible; the company has no material fixed assets. Rights proceeds = 36,65,59,623 shares × INR 1.20 (derived).
Ratios
Sources: Value Research (ROE/ROA FY2024–FY2025 and debt/equity); all other cells derived from the tables above on average-balance basis. The derived ROE/ROA for FY2024–FY2025 match Value Research exactly, which supports the method.
Ratios not applicable or not disclosed: ROIC (not meaningful for a lender); current ratio (NBFCs do not present a classified balance sheet under Ind AS Division III); net debt/EBITDA (cash not disclosed); interest coverage (finance cost not disclosed separately in sources); cash conversion cycle (not applicable). Regulatory ratios (CRAR, Gross/Net Stage-3 assets, provision coverage) are not publicly disclosed in sources retrieved.
Ratio commentary. ARC is extremely under-levered for a lender: about 1.15x assets/equity, against a Base-Layer NBFC leverage ceiling that would permit several times this. Capital is not the constraint; return generation is. ROE has been below 1% in four of the last five years. The 4.4% in FY2025 was a one-off driven by first-half trading gains. Equity nearly doubled after the rights issue while profit fell, so per-share value creation has been negligible: book value per share rose only from about INR 1.01 to INR 1.14 over the period. A rights issue priced at INR 1.20 against a pre-issue book value of about INR 1.01 was accretive by roughly INR 0.08 per share, which accounts for most of that increase.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Revenue by Segment and Segment Margins & Growth (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
Revenue from operations, single segment (INR Cr) | 9.24 | 23.30 | 28.09 |
YoY growth (%) | 33.5 | 152.2 | 20.6 |
Share of total revenue (%) | 100 | 100 | 100 |
Profit before tax (INR Cr) | 0.37 | 4.48 | 0.97 |
PBT margin (%) | 4.0 | 19.2 | 3.5 |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
"Sales" per Capital Market — interest/fee proxy (INR Cr) | 3.08 | 2.54 | 6.14 |
Residual revenue — probable securities sales/trading (INR Cr) | 6.16 | 20.76 | 21.95 |
Proxy share of revenue (%) | 33.3 | 10.9 | 21.9 |
Income Statement and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue from operations / total income (INR Cr) | 32.59 | 6.92 | 9.24 | 23.30 | 28.09 |
Revenue growth YoY (%) | 679.9 | -78.8 | 33.5 | 152.2 | 20.6 |
Total expenses (INR Cr) | — | — | 8.59 | 16.93 | 27.11 |
Operating profit per Indmoney (INR Cr) | 0.43 | 0.52 | 0.57 | 4.76 | 1.26 |
PBDT per Capital Market (INR Cr) | — | — | — | 5.70 | 1.26 |
Profit before tax (INR Cr) | 0.38 | 0.44 | 0.37 | 4.48 | 0.97 |
Net income / PAT (INR Cr) | 0.28 | 0.33 | 0.27 | 3.31 | 0.72 |
Net margin (%) | 0.87 | 4.73 | 2.94 | 14.22 | 2.56 |
EPS basic, derived on period-end shares (INR) | 0.006 | 0.007 | 0.005 | 0.038 | 0.008 |
Dividend per share (INR) | 0 | 0 | 0 | 0 | 0 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansIncome Statement
| Metric | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q1FY27 |
|---|---|---|---|---|---|---|
Total revenue (INR Cr) | 3.65 | 0.82 | 20.05 | 1.58 | 5.64 | 1.84 |
"Sales" per Capital Market (INR Cr) | 0.73 | 0.30 | 1.04 | 0.54 | 4.25 | 1.00 |
Net profit (INR Cr) | -3.46 | 0.13 | 0.12 | -0.01 | 0.48 | 0.17 |
Balance Sheet and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (INR Cr) | 79.27 | 70.94 | 71.51 | 100.35 | 114.02 |
Equity share capital (INR Cr) | 50.50 | 50.50 | 50.50 | 87.15 | 87.15 |
Reserves and surplus (INR Cr) | 0.78 | 1.12 | 0.68 | 11.17 | 11.79 |
Net worth (INR Cr) | 51.28 | 51.62 | 51.18 | 98.32 | 98.94 |
Loans and advances (INR Cr) | — | — | 44.57 | 69.96 | 86.90 |
Investments (INR Cr) | 0.35 | 0.35 | 0.30 | 2.62 | — |
Short-term borrowings (INR Cr) | 25.01 | 13.88 | 15.39 | 0.07 | — |
Long-term borrowings (INR Cr) | 0.31 | 1.02 | 0.79 | 0.75 | — |
Total borrowings (INR Cr) | 25.32 | 14.90 | 16.18 | 0.82 | — |
Liabilities other than equity (INR Cr) | 27.99 | 19.32 | 20.33 | 2.03 | 15.08 |
Book value per share (INR) | 1.02 | 1.02 | 1.01 | 1.13 | 1.14 |
Returns & Leverage Ratios
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Rights-issue gross proceeds (INR Cr) | 0 | 0 | 0 | 43.99 | 0 |
Dividends paid (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (INR Cr) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%) and Financial Ratios (x)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Return on equity (%) | 0.55 | 0.64 | 0.53 | 4.43 | 0.73 |
Return on assets (%) | 0.42 | 0.44 | 0.38 | 3.85 | 0.67 |
Debt to equity (x) | 0.49 | 0.29 | 0.31 | 0.01 | — |
Total assets to net worth (x) | 1.55 | 1.37 | 1.40 | 1.02 | 1.15 |
Loans to total assets (%) | — | — | 62.3 | 69.7 | 76.2 |
Loan book growth (%) | — | — | — | 57.0 | 24.2 |
Asset turnover (revenue / avg assets, x) | 0.49 | 0.09 | 0.13 | 0.27 | 0.26 |
Revenue by Region and Revenue by Region (%)
| Metric | FY2024 | FY2025 | FY2026 |
|---|---|---|---|
India revenue (INR Cr) | 9.24 | 23.30 | 28.09 |
India share of revenue (%) | 100 | 100 | 100 |
India revenue growth YoY (%) | 33.5 | 152.2 | 20.6 |
Outside-India revenue (INR Cr) | 0 | 0 | 0 |
Share Price History
| Date | Price (INR) | Market cap (INR Cr) | Source |
|---|---|---|---|
9 Apr 2020 | 0.02 | — | Business Standard (all-time low) |
24 Feb 2022 | 5.08 | — | Business Standard (all-time high) |
26 Jul 2024 | 1.19 | 60.09 | IIFL |
20 Dec 2024 | 1.55 | 135 | Business Standard |
6 Jan 2025 | 1.58 | 137.70 | IIFL |
16 Sep 2025 | 0.81 | 70.59 | Kotak Securities |
13 Feb 2026 | 0.65 | 56.65 | Choice India |
15 May 2026 | 0.57 | 50 | Value Research |
18 Jun 2026 | 0.55 | ~48 | MarketsMojo |
31 Jul 2026 | 0.51 | 44 | Business Standard |
28 Aug 2026 | 0.47 | 41 | Anand Rathi |
16 Oct 2026 | 0.46 | ~40 | INDmoney / Investing.com |
ARC Finance by Period
| Period (as of 18 Jun 2026) | ARC Finance (%) | Sensex (%) |
|---|---|---|
1 year | -50.0 | -4.95 |
3 years | -12.43 | 22.13 |
5 years | 20.26 | 47.89 |
Valuation Multiples
| Multiple | ARC Finance | Peer reference |
|---|---|---|
P/E (FY2026 PAT INR 0.72 Cr) | ~56x | Peer median P/E ~20x (Value Research, May 2026) |
P/E (TTM to Jun 2026, PAT ~INR 0.76 Cr) | ~53x | Finology reported 52.9x |
P/B (BVPS INR 1.14) | ~0.40x | Peer median ~1.53x (Value Research, May 2026) |
EV/EBITDA | Not computable (cash and FY2026 debt not disclosed) | — |
EV/Sales (approximated by market cap / revenue) | ~1.4x | — |
Dividend yield | 0% | — |
Action Details
| Action | Date | Detail |
|---|---|---|
Dividends | — | None paid in the last 5+ years (0% payout; Zerodha) |
Buybacks | — | None authorised |
Stock split | Ex-date 29 Mar 2022 | 1:10 (FV INR 10 → INR 1) |
Rights issue | Ex-date 10 Oct 2024 | 4:5 at INR 1.20; 36.66 Cr shares allotted 25 Nov 2024 |
Analyst Conclusions
Management guidance
None issued. ARC Finance does not provide financial guidance, hold earnings calls or publish targets.
Consensus expectations
None (no coverage).
Bull case
-
Deep discount to book. At about 0.40x P/B on BVPS of INR 1.14, the market values the company at about INR 40 Cr against net worth of about INR 99 Cr. If the INR 87 Cr loan book is performing, even a modest re-rating toward 0.7–0.8x book implies substantial upside.
-
Latent earnings power. An equity-funded INR 87 Cr book earning a net 8–10% yield after costs could produce INR 5–7 Cr pre-tax annually (illustrative arithmetic, not a forecast). That is several times the FY2026 PAT of INR 0.72 Cr. The FY2026 "sales" proxy of INR 6.14 Cr and Q1 FY2027 revenue of INR 1.84 Cr show interest income building.
-
Balance-sheet optionality. Near-zero leverage (debt/equity 0.01 at FY2025), INR 101 Cr authorised capital and enabling capital clauses give room to scale through modest borrowing without dilution.
Bear case
-
Earnings have not followed capital. Equity nearly doubled, yet FY2026 PAT fell 78% and ROE was 0.73%. On average equity of about INR 99 Cr, the business is destroying value relative to any reasonable cost of equity.
-
Opaque book and income. No disclosed asset quality, borrower concentration or product mix. Revenue swings from INR 0.82 Cr to INR 20.05 Cr between consecutive quarters suggest trading-driven income, and the Q4 FY2025 INR 3.46 Cr loss shows the downside.
-
Governance and alignment. Promoters own 6.97% and declined their rights entitlement. The Chair and MD roles are combined. All three Independent Directors appear to have reached the end of their statutory terms without disclosed successors. Retail shareholders (93%) bear the risk with little influence.
Catalysts and monitorables (next 12 months)
| Item | Timing | What to watch |
|---|---|---|
| Q2 FY2027 results | Expected ~Nov 2026 (trading window closed 28 Sep 2026) | Whether H1 FY2027 PAT run-rate exceeds INR 0.4 Cr; revenue volatility |
| Board reconstitution | Immediate | Appointment of new Independent Directors and reconstitution of the Audit/NRC committees |
| FY2026 annual report detail | Available now on BSE | Stage-2/3 assets, ECL provisions, CRAR, top-borrower concentration, related-party loans, composition of the INR 15 Cr non-equity liabilities |
| Rights-proceeds utilisation | Quarterly | Confirmation that INR 44 Cr went to lending as per the Letter of Offer objects; any variation |
| Shareholding | Quarterly | Promoter buying or selling; entry of any institutional holder |
| Exchange surveillance | Ongoing | Any ASM/GSM/trade-for-trade categorisation |
| RBI | Ongoing | Any supervisory action; SBR compliance |
| Q3 FY2027 / FY2027 results | Feb / May 2027 | Whether FY2027 PAT recovers toward the FY2025 level of INR 3.3 Cr |
Analyst verdict
ARC Finance Limited is a licensed shell of a lender with real capital but little demonstrated earning power. Its history splits into two eras. Until 2021 it was a dormant Kolkata NBFC with about a thousand shareholders and roughly INR 51 Cr of paid-up capital. After 2021 its stock became a retail favourite: the shareholder register grew about 300-fold, the split-adjusted price ran from INR 0.02 to INR 5.08 and back below INR 0.50, and the company used the window to raise about INR 44 Cr through a rights issue at INR 1.20. That issue was the company's most consequential act. It doubled net worth to about INR 99 Cr and funded a loan book that has roughly doubled to INR 87 Cr.
The problem is conversion. FY2026 profit of INR 0.72 Cr on nearly INR 100 Cr of equity is a 0.7% return. Reported revenue is dominated by lumpy securities transactions with negligible margin, and the only strong year (FY2025) was partly reversed by a single quarter's loss. The promoters' choice not to subscribe at INR 1.20 is hard to ignore when the stock now trades at about INR 0.46. Disclosure is thin on the variables that matter most for a lender: asset quality, concentration and funding. A near-term board-compliance question over Independent Director terms adds governance risk.
The discount to book is the entire investment case, and it is a conditional one. If the loan book is sound and management can lift ROE to even 5–6% through steady interest income, the shares are materially undervalued. If the book is concentrated, related-party-heavy or impaired, book value is overstated and the discount is warranted. Until the FY2026 annual report's credit disclosures are examined and two to three quarters of stable, interest-led profit are visible, the stock is best treated as a speculative, low-transparency nano-cap. It is not suitable for institutional mandates and warrants position sizing on that basis.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | DIN | On board since | Tenure (yrs, to Oct 2026) | Notes | Source |
|---|---|---|---|---|---|---|
Virendra Kumar Soni | Managing Director & Chairperson (Executive) | 08,554,333 | 5 Sep 2019 | 7.1 | Whole-Time Director from Sep 2023; MD from 9 Nov 2023; 5-year MD term approved at 2024 AGM. Reported age 47 (S&P data, 2025). | BSE governance filing; Simply Wall St; 2024 AGM notice |
Somnath Chitrakar | Executive Director & CFO | 09,678,491 | 1 Aug 2022 | 4.2 | Also designated Whole-Time Director | BSE governance filing; Simply Wall St; 2023 AGM notice |
Gopal Singh | Independent Director (Non-Executive) | 06,739,896 | 5 Feb 2014 | 12.7 | Re-appointed 29 Sep 2021 for 5 years | BSE governance filing |
Asis Banerjee | Independent Director (Non-Executive) | 05,273,668 | 5 Feb 2014 | 12.7 | Re-appointed 29 Sep 2021 for 5 years | BSE governance filing |
Aparna Sharma | Independent Director (Non-Executive) | 07,006,877 | 25 Mar 2015 | 11.6 | Re-appointed 29 Sep 2021 for 5 years | BSE governance filing |
Shikha Singhal | Director (Executive per Choice India) | — | Appointed Additional Director during FY2025 | ~1.5–2 | Category per aggregators | FY2025 Directors' Report; Choice India |
Surojit Sarkar | Former Executive Director | 09,672,539 | 5 Sep 2023 | — | — | 2023 AGM notice; FY2025 Directors' Report |
Sweety Agarwal | Company Secretary & Compliance Officer | — | Appointed after 26 Apr 2024 | <2.5 | Replaced Neha Gandhi | FY2025 Directors' Report; Simply Wall St |
Neha Gandhi | Former Company Secretary | — | — | — | Resigned 26 Apr 2024 | BSE filing 26 Apr 2024 |
“—” = not publicly disclosed.
Governance Overview
| Attribute | Assessment |
|---|---|
Board size | 6 (as of latest governance filing reviewed; includes Surojit Sarkar before his resignation) |
Independent directors | 3 of 6 (50%), which meets the SEBI LODR 50% requirement where the chair is an executive director |
Women directors | Aparna Sharma (ID), Shikha Singhal |
Chair / CEO separation | No. Virendra Kumar Soni is both Chairperson and MD |
Board evaluation | Annual evaluation by Board and Independent Directors described in Directors' Report |
Average board tenure | About 10.2 years (Simply Wall St); management tenure about 1.5 years |
Board & Management Changes
| Date | Change | Context |
|---|---|---|
1 Aug 2022 | Somnath Chitrakar appointed Executive Director | Management rebuild |
5 Sep 2023 | Surojit Sarkar appointed Executive Director; Soni elevated to WTD | 41st AGM cycle |
9 Nov 2023 | Soni appointed MD | Ahead of rights issue |
26 Apr 2024 | CS Neha Gandhi resigns; Sweety Agarwal appointed | Routine KMP turnover |
FY2025 | Shikha Singhal appointed Additional Director; Surojit Sarkar resigns | Board refresh |
30 Sep 2026 | Woman director retiring by rotation re-appointed at 44th AGM | Name truncated in source |
Governance Overview (Annual)
| Metric | Mar2022 | Mar2023 | Mar2024 | Mar2025 | Mar2026 |
|---|---|---|---|---|---|
Promoter holding (%) | 12.02 | 12.02 | 12.02 | 6.97 | 6.97 |
FII holding (%) | 0.00 | 0.00 | 0.00 | 0.06 | 0.00 |
Public holding (%) | 87.98 | 87.98 | 87.97 | 92.97 | 93.03 |
Number of shareholders | 46,601 | 82,068 | 182,228 | 312,636 | 323,368 |
Competitive Landscape
Key Competitors
| # | Peer | Basis of peer identification | Disclosed comparative metric | Source |
|---|---|---|---|---|
| 1 | Sita Enterprises | Zerodha "major competitors" | Market cap peer median about INR 43 Cr | Zerodha |
| 2 | Morgan Ventures | Zerodha; Business Standard | Same | Zerodha; Business Standard |
| 3 | Key Corp | Zerodha | Same | Zerodha |
| 4 | Lakshmi Finance | Zerodha | Same | Zerodha |
| 5 | Odyssey Corporation | Business Standard peer list | — | Business Standard |
| 6 | WSFX Global | Business Standard peer list | — | Business Standard |
| 7 | Asit C Mehta Financial Services | Business Standard peer list | — | Business Standard |
| 8 | Credent Global Finance | Business Standard peer list | — | Business Standard |
| 9 | Transwarranty Finance | Business Standard peer list | — | Business Standard |
| 10 | Caspian Corporate Services | Askfuzz NBFC ROE comparison | ROE 19.00% | Askfuzz (Feb 2026) |
| 11 | Everlon Finance | Askfuzz | ROE 16.16% | Askfuzz |
| 12 | Real Touch Finance | Askfuzz | ROE 6.20% | Askfuzz |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | ARC Finance | Caspian Corporate | Everlon Finance | Real Touch Finance |
|---|---|---|---|---|
ROE (%) | 2.52 (TTM to Dec 2025) | 19.00 | 16.16 | 6.20 |
Revenue (INR Cr) | 28.09 (FY2026) | — | — | — |
Revenue growth (%) | 20.6 (FY2026) | — | — | — |
Net margin (%) | 2.6 (FY2026) | — | — | — |
R&D intensity (%) | 0 | — | — | — |
“—” = not publicly disclosed.
Recent Developments
Not identified in this period: * contract wins, product launches, guidance revisions, litigation, regulatory penalties, layoffs or restructuring.



